Dissecting the Immune Stimulation Promoted by CSF-470 Vaccine Plus Adjuvants in Cutaneous Melanoma Patients: Long Term Antitumor Immunity and Short Term Release of Acute Inflammatory Reactants

As cutaneous melanoma (CM) currently remains with a bleak prognosis, thorough investigation of new treatment options are of utmost relevance. In the phase II/III randomized clinical trial (CASVAC-0401), the repeated immunization of stages IIB-III CM patients with the irradiated, allogeneic cellular...

Descripción completa

Detalles Bibliográficos
Autores principales: Pampena, María B., Cartar, Holliday C., Cueto, Gerardo Rubén, Levy, Estrella M., Blanco, Paula A., Barrio, María M., Mordoh, José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6224428/
https://www.ncbi.nlm.nih.gov/pubmed/30450100
http://dx.doi.org/10.3389/fimmu.2018.02531

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6224428/
https://www.ncbi.nlm.nih.gov/pubmed/30450100
http://dx.doi.org/10.3389/fimmu.2018.02531

Ejemplares similares